id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-2836-0016,FDA,FDA-2016-N-2836,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2020-09-15T04:00:00Z,2020,9,2020-09-15T04:00:00Z,,2020-09-15T13:25:54Z,2020-20332,0,0,09000064848599d4
FDA-2016-N-2836-0014,FDA,FDA-2016-N-2836,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Donor Risk
Assessment Questionnaire for the Food and Drug Administration/National Heart, Lung, and Blood Institute- Sponsored Transfusion-Transmissible Infections Monitoring System—Risk Factor Elicitation",Notice,30 Day Proposed Information Collection,2020-07-13T04:00:00Z,2020,7,2020-07-13T04:00:00Z,2020-08-13T03:59:59Z,2020-08-13T01:01:05Z,2020-15009,0,0,0900006484745b75
FDA-2016-N-2836-0011,FDA,FDA-2016-N-2836,"Agency Information Collection Activities; Proposed Collection; Comment Request; Donor Risk Assessment Questionnaire for the Food and Drug Administration/National Heart, Lung, and Blood Institute Sponsored Transfusion-Transmissible Infections Monitoring System—Risk Factor Elicitation",Notice,60 Day Proposed Information Collection,2020-01-08T05:00:00Z,2020,1,2020-01-08T05:00:00Z,2020-03-10T03:59:59Z,2020-02-12T02:02:51Z,2020-00047,0,0,090000648427be19